Abstract
BackgroundLow-dose amitriptyline, a tricyclic antidepressant (TCA), was superior to placebo for irritable bowel syndrome (IBS) in the AmitripTyline at Low-dose ANd Titrated for Irritable bowel syndrome as Second-line treatment (ATLANTIS)...
Published Version
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have